Clinical Trials Logo

Indirect Pulp Cap clinical trials

View clinical trials related to Indirect Pulp Cap.

Filter by:
  • None
  • Page 1

NCT ID: NCT04863222 Recruiting - Pulpotomy Clinical Trials

Clinical and Radiographic Success of MTA vs Biodentine

Start date: November 12, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this prospective study is to compare the clinical and radiographic success of MTA and Biodentine as a medicament in vital pulp therapy in maxillary and mandibular primary molars in a pediatric population. There is limited research currently on Biodentine since it's a novel product. Biodentine is less expensive than MTA and does not cause discoloration like MTA. Biodentine may be an alternative medicament used for vital pulp therapy in primary molars.

NCT ID: NCT02298504 Active, not recruiting - Pulpotomy Clinical Trials

Vital Pulp Treatment in Primary Teeth

Start date: July 1, 2018
Phase: Phase 4
Study type: Interventional

In primary teeth, decay that is near the pulp (tooth nerve)is treated with either a pulpotomy or indirect pulp treatment if the tooth is not going to be extracted A pulpotomy involves removing the top 1/2 of the pulp, placing a medication/material on the pulp, covering the remaining pulp with a cement, and the restoring the tooth. The purpose of this pilot study is to gain preliminary information regarding the success of Biodentine, MTA, and IPT in the treatment of deep decay in children's primary molars.